Evidence map›Paper›PMID 32894672›Full record

ArticleChemical research in toxicology2020

Protective Role of Glutathione against Peroxynitrite-Mediated DNA Damage During Acute Inflammation.

Nabeel Ahmed, Anindita Chakrabarty, F Peter Guengerich, Goutam Chowdhury

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Chemical research in toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04374461 (Phase II Study of N-acetylcysteine in Severe or Critically Ill Patients With Refractory COVID-19 Infection), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04374461 phase2active not recruitingnot on this map

Phase II Study of N-acetylcysteine in Severe or Critically Ill Patients With Refractory COVID-19 Infection

TypeinterventionalSponsorMemorial Sloan Kettering Cancer CenterRan2020 to 2027Enrolled48ConditionsCovid-19ArmsN-acetylcysteine, Peripheral Blood
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Nabeel Ahmed
Anindita Chakrabarty
F Peter GuengerichDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States.ORCID 0000-0002-7458-3048
Shiv Nadar University · INVanderbilt University · US

Funding

BIOACTIVATION OF HALOGENATED HYDROCARBONSR01ES010546 · NIEHS · VANDERBILT UNIVERSITY · PI GUENGERICH, F PETER · 2001 to 2020
$8.1M
NIEHS NIH HHS R01 ES010546
6 · The paper itself

Abstract

Inflammation is an immune response to protect against various types of infections. When unchecked, acute inflammation can be life-threatening, as seen with the current coronavirus pandemic. Strong oxidants, such as peroxynitrite produced by immune cells, are major mediators of the inflammation-associated pathogenesis. Cellular thiols play important roles in mitigating inflammation-associated macromolecular damage including DNA. Herein, we have demonstrated a role of glutathione (GSH) and other thiols in neutralizing the effect of peroxynitrite-mediated DNA damage through stable GSH-DNA adduct formation. Our observation supports the use of thiol supplements as a potential therapeutic strategy against severe COVID-19 cases and a Phase II (NCT04374461) open-label clinical trial launched in early May 2020 by the Memorial Sloan Kettering Cancer Center.

Indexed as

Acute DiseaseAnimalsBetacoronavirusCattleCoronavirus InfectionsCOVID-19DNADNA AdductsDNA DamageGlutathioneHEK293 CellsHumansInflammationMutagensPandemicsPeroxynitrous Acidcalf thymus DNADNADNA AdductsGlutathioneMutagensPeroxynitrous Acid

Identifiers

PMID32894672
PMCPMC9297005
OpenAlexW3083290710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.